Stay updated on Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.

Latest updates to the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe completed phase 3 JAVELIN Renal 101 study record is displayed, with its treatment arms, eligibility criteria, outcome measures, locations, publications, and Pfizer data-sharing and study-document links.SummaryDifference100%

- Check14 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0; the study record remains unavailable on the 403 error page.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH notice appears above the blocked study record, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check28 days agoChange DetectedThe site footer revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden message.SummaryDifference0.2%

- Check56 days agoChange DetectedAccess to the study record has been replaced by a 403 Forbidden page, effectively hiding the study details and related navigation. The change represents a site-level access issue that prevents users from viewing the trial information on this page.SummaryDifference18%

Stay in the know with updates to Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab/Axitinib vs Sunitinib in Advanced Renal Cell Cancer Clinical Trial page.